You just read:

Phase 3 CREDENCE Renal Outcomes Trial of INVOKANA® (canagliflozin) is Being Stopped Early for Positive Efficacy Findings

News provided by

The Janssen Pharmaceutical Companies of Johnson & Johnson

Jul 16, 2018, 16:15 ET